Establishment of fundamental research resource of rare cancer: Multi-institutional collaboration and networking

Rare cancer research has a unique situation: “Number of patients is small, and clinical materials are hardly available for research”. Probably because the clinical materials are not well available for research in rare cancers, the fundamental research tools are not well developed. Division of Rare Cancer Research addresses this issue.

Multi-institutional collaboration and networking

We conduct the multi-institutional collaborations to investigate the novel innovative seeds for rare cancers by using clinical materials. The participants include the domestic universities which conduct clinical practice and research of rare cancers, as well as the oversea researchers who focus on the rare cancers. In addition to the establishment of patient-derived cancer models of sarcomas and malignant brain tumors, we perform the multi-layer omics studies of rare cancers. Our collaborations will enable the research which is difficult to be done by single institutions. We will share the research outcomes by discussions, so that all participants can be benefited by the collaborations. We will use the results of collaborations to promote novel therapies by getting patents and industrialization of the developed innovative seeds.